|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.090 USD | +1.95% |
|
+5.03% | +16.11% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 08/06/2026 | 09/06/2026 | 10/06/2026 | 11/06/2026 | 12/06/2026 | |
|---|---|---|---|---|---|
| Last | 1.960 $ | 1.980 $ | 1.970 $ | 2.050 $ | 2.090 $ |
| Volume | 4,54,663 | 4,60,545 | 3,60,834 | 6,03,536 | 2,54,955 |
| Change | -1.51% | +1.02% | -0.51% | +4.06% | +1.95% |
| Opening | 1.970 $ | 1.960 $ | 1.980 $ | 1.990 $ | 2.070 $ |
| High | 2.020 $ | 2.025 $ | 2.010 $ | 2.075 $ | 2.110 $ |
| Low | 1.945 $ | 1.960 $ | 1.960 $ | 1.970 $ | 2.060 $ |
Performance
| 1 day | +1.95% | ||
| 1 week | +5.03% | ||
| Current month | -0.95% | ||
| 1 month | +8.29% | ||
| 3 months | -26.15% | ||
| 6 months | +16.76% | ||
| Current year | +16.11% | ||
| 1 year | +40.27% | ||
| 3 years | -8.73% | ||
| 5 years | -3.69% | ||
| 10 years | -72.50% |
Volumes
marketsDaily volume
2,54,955
Estimated daily volume
2,54,955
Avg. Volume 20 sessions
6,43,541
Daily volume ratio
0.4
Avg. Volume 20 sessions USD
13,45,000.69
Record volume 1
19,12,89,000
Record volume 2
1,94,14,390
Record volume 3
1,27,16,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
16,83,94,731
Net sales (USD)
5,27,44,000
Number of employees
226
Sales / Employee (USD)
2,33,381
Free-Float
96.12 %
Free-Float capitalization (USD)
16,18,64,727
Average Daily Capital Traded
0.8%
Indicators
Moving average 5 days
1.99
Moving average 20 days
2.018
Moving average 50 days
2.102
Moving average 100 days
2.35
Price spread / (MMA5)
-4.78%
Price spread / (MMA20)
-3.42%
Price spread / (MMA50)
+0.56%
Price spread / (MMA100)
+12.45%
RSI 9 days
55.19
RSI 14 days
50.86
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | +5.03% | +40.27% | -8.73% | 17Cr | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,01000Cr | |
| +1.07% | +3.48% | +53.32% | +49.85% | 58TCr | |
| +1.32% | +0.22% | +19.18% | +64.65% | 40TCr | |
| +0.77% | 0.00% | +21.28% | +16.70% | 33TCr | |
| +0.44% | +3.48% | +25.65% | +35.66% | 28TCr | |
| -0.85% | -2.86% | +22.54% | +14.67% | 28TCr | |
| +1.66% | +1.20% | -44.35% | -47.35% | 20TCr | |
| +0.32% | +1.61% | +20.32% | +60.01% | 19TCr | |
| -0.22% | -2.76% | +14.19% | +60.09% | 16TCr | |
| Average | +0.41% | +0.96% | +21.07% | +39.97% | 34.29TCr | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.77% | +70.54% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
0d68bf6.hoBRzDK6REL8nrnB3sVX0T87Yr7o8r7S_pMqA4KXwbw.w-sapHXdEg7F8o7xhvwBhgZ8LJOhpu2Hl-BBc_Xtuf3stRSPBe8iBbem2g
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 2.090 | 23,917 | 2,01,758 |
| 01:29:56 am | 2.090 | 175 | 1,77,841 |
| 01:29:56 am | 2.090 | 200 | 1,77,666 |
| 01:29:56 am | 2.090 | 100 | 1,77,466 |
| 01:29:52 am | 2.085 | 100 | 1,77,366 |
| 01:29:50 am | 2.085 | 498 | 1,77,266 |
| 01:29:50 am | 2.090 | 200 | 1,76,768 |
| 01:29:49 am | 2.085 | 191 | 1,76,568 |
| 01:29:48 am | 2.085 | 900 | 1,76,377 |
| 01:29:47 am | 2.090 | 100 | 1,75,477 |
Course Extremes
| 1 week | 1.94 |  | 2.11 |
| 1 month | 1.88 | | 2.18 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.32 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +16.11% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
